Editorial: Emerging Immunotargets in Genitourinary Tumors

Curr Drug Targets. 2016;17(7):748-9. doi: 10.2174/138945011707160412185542.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • B7-H1 Antigen / metabolism
  • CTLA-4 Antigen / metabolism
  • Female
  • Humans
  • Immunotherapy
  • Male
  • Prognosis
  • Programmed Cell Death 1 Receptor / metabolism
  • Urogenital Neoplasms / immunology*
  • Urogenital Neoplasms / pathology*
  • Urogenital Neoplasms / therapy

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor